Market Research Logo

Biologic Excipients Market: Polymers Projected to Remain Most Lucrative Excipient During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Biologic Excipients Market: Polymers Projected to Remain Most Lucrative Excipient During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Future Market Insights (FMI) offers a 10-year forecast on the global biologic excipients market. The primary objective of the report is to offer updates and information related to market opportunities in the global biologic excipients market.

Report Description

In terms of revenue, the global biologic excipients market is expected to register a CAGR of 3.6% during the forecast period, 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global biologic excipients market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global biologic excipients market are presented in the report.

The global market for biologic excipients is expected to witness moderate growth rate in terms of value owing to rising global demand for medicines from emerging economies pushing local drug production, greater uptake of biologics driving demand for parenteral formulation, increasing acquisition of contract research organizations (cros), increasing demand for oral solid liquid formulation, patent-expiration of major blockbuster drugs, growing adoption of advanced drug delivery technologies and growing adoption of advanced drug delivery technologies driving global revenues is creating high potential growth opportunities for players operating in the global biologic excipients market.

Revenue from the biologic excipients market in North America is expected to expand at relatively higher CAGR due to growing adoption of advanced drug delivery technologies coupled with rising global demand for medicines. To understand and assess opportunities in biologic excipients market market, the report offers market forecast on the basis of segment type classified into excipient type, end user and regions. The report provides analysis of global biologic excipients market in terms of market value (US$ Mn).

The global biologic excipients market is segmented on the basis of excipient type into:

Polymers

Sugar Alcohols

Polysorbates

Inorganic Salts

Amino Acids

Surfactants

Others

The report begins with definition of biologic excipients market, followed by definition of different biologic excipients product types. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global biologic excipients market.

The report analyses biologic excipients market on the basis of end users and presents forecast in terms of value for the next 10 years. On the basis of end users, the global biologic excipients market is categorized into:

Biopharmaceutical Manufacturers

Contract Research Organizations/Contract Manufacturing Organizations

Research Organizations

Next, the report analyses biologic excipients market on the basis of regions and presents forecast in terms of value for the next 10 years. On the basis of regions, the global biologic excipients market is segmented into:

North America

US

Canada

Latin America

Brazil

Mexico

Rest of Latin America

Western Europe

UK

France

Germany

Italy

Spain

Rest of Western Europe

Eastern Europe

Russia

Poland

Rest of Eastern Europe

Asia Pacific

India

Australia & New Zealand

ASEAN

Rest of APEJ

Japan

China

Middle East & Africa (MEA)

GCC Countries

South Africa

Rest of MEA

In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global biologic excipients market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by biologic excipients market. To understand key segments in terms of their growth and performance in the global biologic excipients market, Future Market Insights has developed a market attractiveness index. The resulting index would help providers identify existing market opportunities.

In the final section of the report, a ‘competitive landscape’ has been included to provide a dashboard view of key companies operating in the global biologic excipients market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the biologic excipients market and the potential players. However, this section also includes market strategies and SWOT analysis of the main players operational in the global biologic excipients market.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Biologic Excipients Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Global Economic Outlook
4.1. Global Gross Domestic Product by Region & Country
4.2. Biologic Excipients Market Outlook
5. Market Background
5.1. List of Growth Hacking Manufacturers
5.2. Market Dynamics
5.2.1. Drivers
5.2.1.1. Supply Side Drivers
5.2.1.2. Demand Side Drivers
5.2.2. Restraints
6. Macroeconomic Assumptions
7. Global Economic Outlook
7.1. Gross Domestic Product by Region & Country, 2006 – 2021
8. Global Supply Demand Analysis
9. Key Inclusions
9.1. Key Competitors
9.2. Usage Trend In Biologic Excipients Industry
10. North America Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
10.3.1. U.S.
10.3.2. Canada
10.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
10.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
10.5.1. Polymers
10.5.2. Sugar Alcohols
10.5.3. Polysorbates
10.5.4. Inorganic Salts
10.5.5. Amino Acids
10.5.6. Surfactants
10.5.7. Others
10.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
10.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
10.7.1. Biopharmaceutical Manufacturers
10.7.2. Contract Research Organizations/Contract Manufacturing Organizations
10.7.3. Research Organizations
10.8. Market Size (US$ Mn) Forecast By End User, 2018–2028
10.9. Market Attractiveness Analysis
10.9.1. By Country
10.9.2. By Excipient Type
10.9.3. By End User
10.10. Key Market Participants – Intensity Mapping
10.11. Drivers and Restraints: Impact Analysis
11. Western Europe Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
11.3.1. Germany
11.3.2. U.K
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Western Europe
11.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
11.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
11.5.1. Polymers
11.5.2. Sugar Alcohols
11.5.3. Polysorbates
11.5.4. Inorganic Salts
11.5.5. Amino Acids
11.5.6. Surfactants
11.5.7. Others
11.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
11.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
11.7.1. Biopharmaceutical Manufacturers
11.7.2. Contract Research Organizations/Contract Manufacturing Organizations
11.7.3. Research Organizations
11.8. Market Size (US$ Mn) Forecast By End User, 2018–2028
11.9. Market Attractiveness Analysis
11.9.1. By Country
11.9.2. By Excipient Type
11.9.3. By End User
11.10. Key Market Participants – Intensity Mapping
11.11. Drivers and Restraints: Impact Analysis
12. Eastern Europe Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
12.1. Introduction
12.2. Regional Market Trends
12.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
12.3.1. Russia
12.3.2. Poland
12.3.3. Rest of Eastern Europe
12.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
12.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
12.5.1. Polymers
12.5.2. Sugar Alcohols
12.5.3. Polysorbates
12.5.4. Inorganic Salts
12.5.5. Amino Acids
12.5.6. Surfactants
12.5.7. Others
12.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
12.7.1. Biopharmaceutical Manufacturers
12.7.2. Contract Research Organizations/Contract Manufacturing Organizations
12.7.3. Research Organizations
12.8. Market Size (US$ Mn) Forecast By End User, 2018–2028
12.9. Market Attractiveness Analysis
12.9.1. By Country
12.9.2. By Excipient Type
12.9.3. By End User
12.10. Key Market Participants – Intensity Mapping
12.11. Drivers and Restraints: Impact Analysis
13. Latin America Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
13.1. Introduction
13.2. Regional Market Trends
13.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
13.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
13.5.1. Polymers
13.5.2. Sugar Alcohols
13.5.3. Polysorbates
13.5.4. Inorganic Salts
13.5.5. Amino Acids
13.5.6. Surfactants
13.5.7. Others
13.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
13.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
13.7.1. Biopharmaceutical Manufacturers
13.7.2. Contract Research Organizations/Contract Manufacturing Organizations
13.7.3. Research Organizations
13.8. Market Size (US$ Mn) Forecast By End User, 2018–2028
13.9. Market Attractiveness Analysis
13.9.1. By Country
13.9.2. By Excipient Type
13.9.3. By End User
13.10. Key Market Participants – Intensity Mapping
13.11. Drivers and Restraints: Impact Analysis
14. Asia Pacific Excluding China & Japan Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
14.1. Introduction
14.2. Regional Market Trends
14.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
14.3.1. India
14.3.2. Australia and New Zealand
14.3.3. ASEAN
14.3.4. Rest of APECJ
14.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
14.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
14.5.1. Polymers
14.5.2. Sugar Alcohols
14.5.3. Polysorbates
14.5.4. Inorganic Salts
14.5.5. Amino Acids
14.5.6. Surfactants
14.5.7. Others
14.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
14.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
14.7.1. Biopharmaceutical Manufacturers
14.7.2. Contract Research Organizations/Contract Manufacturing Organizations
14.7.3. Research Organizations
14.8. Market Size (US$ Mn) Forecast By End User, 2018–2028
14.9. Market Attractiveness Analysis
14.9.1. By Country
14.9.2. By Excipient Type
14.9.3. By End User
14.10. Key Market Participants – Intensity Mapping
14.11. Drivers and Restraints: Impact Analysis
15. China Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
15.1. Introduction
15.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
15.2.1. Polymers
15.2.2. Sugar Alcohols
15.2.3. Polysorbates
15.2.4. Inorganic Salts
15.2.5. Amino Acids
15.2.6. Surfactants
15.2.7. Others
15.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
15.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
15.4.1. Biopharmaceutical Manufacturers
15.4.2. Contract Research Organizations/Contract Manufacturing Organizations
15.4.3. Research Organizations
15.5. Market Size (US$ Mn) Forecast By End User, 2018–2028
15.6. Market Attractiveness Analysis
15.6.1. By Excipient Type
15.6.2. By End User
15.7. Key Market Participants – Intensity Mapping
15.8. Drivers and Restraints: Impact Analysis
16. Japan Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
16.1. Introduction
16.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
16.2.1. Polymers
16.2.2. Sugar Alcohols
16.2.3. Polysorbates
16.2.4. Inorganic Salts
16.2.5. Amino Acids
16.2.6. Surfactants
16.2.7. Others
16.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
16.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
16.4.1. Biopharmaceutical Manufacturers
16.4.2. Contract Research Organizations/Contract Manufacturing Organizations
16.4.3. Research Organizations
16.5. Market Size (US$ Mn) Forecast By End User, 2018–2028
16.6. Market Attractiveness Analysis
16.6.1. By Excipient Type
16.6.2. By End User
16.7. Key Market Participants – Intensity Mapping
16.8. Drivers and Restraints: Impact Analysis
17. Middle East and Africa Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
17.1. Introduction
17.2. Regional Market Trends
17.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
17.3.1. GCC Countries
17.3.2. South Africa
17.3.3. Rest of MEA
17.4. Market Size (US$ Mn) Forecast By Country, 2018–2028
17.5. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
17.5.1. Polymers
17.5.2. Sugar Alcohols
17.5.3. Polysorbates
17.5.4. Inorganic Salts
17.5.5. Amino Acids
17.5.6. Surfactants
17.5.7. Others
17.6. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
17.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
17.7.1. Biopharmaceutical Manufacturers
17.7.2. Contract Research Organizations/Contract Manufacturing Organizations
17.7.3. Research Organizations
17.8. Market Size (US$ Mn) Forecast By End User, 2018–2028
17.9. Market Attractiveness Analysis
17.9.1. By Country
17.9.2. By Excipient Type
17.9.3. By End User
17.10. Key Market Participants – Intensity Mapping
17.11. Drivers and Restraints: Impact Analysis
18. Forecast Factors: Relevance and Impact
19. Forecast Assumptions
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competitors Deep Dive
20.3.1. Roquette Frères
20.3.1.1. Overview
20.3.1.2. Product and Application Portfolio
20.3.1.3. Production Footprint
20.3.1.4. Sales Footprint
20.3.1.5. Channel Footprint
20.3.1.6. Strategy
20.3.1.6.1. Marketing Strategy
20.3.1.6.2. Product Strategy
20.3.1.6.3. Channel Strategy
20.3.2. The Dow Chemical Company
20.3.2.1. Overview
20.3.2.2. Product and Application Portfolio
20.3.2.3. Production Footprint
20.3.2.4. Sales Footprint
20.3.2.5. Channel Footprint
20.3.2.6. Strategy
20.3.2.6.1. Marketing Strategy
20.3.2.6.2. Product Strategy
20.3.2.6.3. Channel Strategy
20.3.3. FMC Corporation
20.3.3.1. Overview
20.3.3.2. Product and Application Portfolio
20.3.3.3. Production Footprint
20.3.3.4. Sales Footprint
20.3.3.5. Channel Footprint
20.3.3.6. Strategy
20.3.3.6.1. Marketing Strategy
20.3.3.6.2. Product Strategy
20.3.3.6.3. Channel Strategy
20.3.4. Ashland Inc.
20.3.4.1. Overview
20.3.4.2. Product and Application Portfolio
20.3.4.3. Production Footprint
20.3.4.4. Sales Footprint
20.3.4.5. Channel Footprint
20.3.4.6. Strategy
20.3.4.6.1. Marketing Strategy
20.3.4.6.2. Product Strategy
20.3.4.6.3. Channel Strategy
20.3.5. Signet Chemical Corporation Pvt. Ltd.
20.3.5.1. Overview
20.3.5.2. Product and Application Portfolio
20.3.5.3. Production Footprint
20.3.5.4. Sales Footprint
20.3.5.5. Channel Footprint
20.3.5.6. Strategy
20.3.5.6.1. Marketing Strategy
20.3.5.6.2. Product Strategy
20.3.5.6.3. Channel Strategy
20.3.6. BASF Corporation
20.3.6.1. Overview
20.3.6.2. Product and Application Portfolio
20.3.6.3. Production Footprint
20.3.6.4. Sales Footprint
20.3.6.5. Channel Footprint
20.3.6.6. Strategy
20.3.6.6.1. Marketing Strategy
20.3.6.6.2. Product Strategy
20.3.6.6.3. Channel Strategy
20.3.7. Colorcon
20.3.7.1. Overview
20.3.7.2. Product and Application Portfolio
20.3.7.3. Production Footprint
20.3.7.4. Sales Footprint
20.3.7.5. Channel Footprint
20.3.7.6. Strategy
20.3.7.6.1. Marketing Strategy
20.3.7.6.2. Product Strategy
20.3.7.6.3. Channel Strategy
20.3.8. The Archer Daniels Midland Company
20.3.8.1. Overview
20.3.8.2. Product and Application Portfolio
20.3.8.3. Production Footprint
20.3.8.4. Sales Footprint
20.3.8.5. Channel Footprint
20.3.8.6. Strategy
20.3.8.6.1. Marketing Strategy
20.3.8.6.2. Product Strategy
20.3.8.6.3. Channel Strategy
20.3.9. Wacker Chemie AG
20.3.9.1. Overview
20.3.9.2. Product and Application Portfolio
20.3.9.3. Production Footprint
20.3.9.4. Sales Footprint
20.3.9.5. Channel Footprint
20.3.9.6. Strategy
20.3.9.6.1. Marketing Strategy
20.3.9.6.2. Product Strategy
20.3.9.6.3. Channel Strategy
20.3.10. Evonik Industries
20.3.10.1. Overview
20.3.10.2. Product and Application Portfolio
20.3.10.3. Production Footprint
20.3.10.4. Sales Footprint
20.3.10.5. Channel Footprint
20.3.10.6. Strategy
20.3.10.6.1. Marketing Strategy
20.3.10.6.2. Product Strategy
20.3.10.6.3. Channel Strategy
21. Global Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028 By Region
21.1. Introduction / Key Findings
21.2. Historical Market Size (US$ Mn) Analysis By Region
21.2.1. North America
21.2.2. Western Europe
21.2.3. Eastern Europe
21.2.4. Latin America
21.2.5. Asia Pacific Excluding Japan And China
21.2.6. China
21.2.7. Japan
21.2.8. Middle East and Africa
21.3. Market Size (US$ Mn) Forecast By Region
21.3.1. North America
21.3.2. Western Europe
21.3.3. Eastern Europe
21.3.4. Latin America
21.3.5. Asia Pacific Excluding Japan And China
21.3.6. China
21.3.7. Japan
21.3.8. Middle East and Africa
21.4. Market Attractiveness Analysis By Region
22. Global Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028, By Excipient Type
22.1. Introduction/Key Finding
22.2. Historical Market Size (US$ Mn) & Trend Analysis By Excipient Type, 2013-2017
22.2.1. Polymers
22.2.2. Sugar Alcohols
22.2.3. Polysorbates
22.2.4. Inorganic Salts
22.2.5. Amino Acids
22.2.6. Surfactants
22.2.7. Others
22.3. Market Size (US$ Mn) & Forecast By Excipient Type, 2018–2028
22.4. Market Attractiveness Analysis By Excipient Type
23. Global Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028, By End User
23.1. Introduction/Key Finding
23.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
23.2.1. Biopharmaceutical Manufacturers
23.2.2. Contract Research Organizations/Contract Manufacturing Organizations
23.2.3. Research Organizations
23.3. Market Size (US$ Mn) Forecast By End User, 2018–2028
24. Global Biologic Excipients Market Analysis 2013-2017 and Forecast 2018–2028
24.1. Market Value Share Analysis By All Segment
24.2. Y-o-Y Growth Analysis By All Segment
24.3. Absolute $ Opportunity
25. Assumptions and Acronyms Used
26. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report